A longevity and wellness clinic in Al Safa 2 with a first-party peptide-therapy service page.
Availability does not establish approval or effectiveness. Ask for the exact active ingredient, product registration, indication, prescriber, dispensing source, risks, alternatives, and follow-up plan.
Menovivre names these compounds on its own peptide-therapy page. The page's clinical and regulatory statements are attributed to the clinic; exact product registration and indication should be verified separately. Listing does not establish safety or efficacy.
Menovivre's public peptide-therapy page does not list peptide-specific prices.
Request an itemised written quote that identifies the exact product, clinical services, monitoring and follow-up included.
Price information is attributed to the clinic and may change. It does not establish medical approval, product registration, effectiveness or the total cost of care.
These labels assess the named molecule, not the clinic’s particular product, protocol or marketing claim. UAE registration remains product and indication specific.
| Peptide | Category | Evidence | Approval note | Editorial assessment |
|---|---|---|---|---|
| AOD-9604 | Experimental compound | Limited | Not established for broad weight-loss use | Early research does not establish the broad weight-management outcomes frequently used in marketing. |
| Epitalon | Experimental compound | Limited | Not established as an approved human medicine | Longevity claims are not supported by robust, independently replicated clinical evidence. |
| MOTS-c | Experimental compound | Preclinical | Not established as an approved human medicine | Metabolic and longevity claims remain predominantly experimental and are not established clinical outcomes. |
8:00am–7:00pm, Monday–Friday; 8:00am–4:00pm, Sunday
+971 50 312 9316Compare clinical assessment, product traceability, informed consent, monitoring, adverse-event support, and alternatives—not marketing claims.
Is this information outdated? Send the editorial team a correction.Clinics cannot pay to change directory order or evidence classifications.